Microba life sciences and ginkgo bioworks announce partnership to discover novel live biotherapeutics

Brisbane, australia & boston--(business wire)--microba life sciences (asx: map), a precision microbiome science company, and ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, today announced a partnership to identify single-strain, live bacteria product (lbp) candidates against autoimmune diseases. the collaboration aims to build on microba's precision approach to lbp development with an in-depth evaluation of the company's strains using ginkgo's high throughput
DNA Ratings Summary
DNA Quant Ranking